1. Antimicrobial Prescription Assessment Tool (AmPAT) development and validation for assessing the rationality of antimicrobial prescriptions in primary and secondary healthcare settings in India.
- Author
-
Bansal, Adarsh, Gupta, Madhu, Shafiq, Nusrat, Saroch, Atul, Kiran, Tanvi, and Muralidharan, Jayashree
- Subjects
- *
SECONDARY care (Medicine) , *MEDICAL prescriptions , *CRONBACH'S alpha , *PRIMARY health care , *ANTIMICROBIAL stewardship , *RESEARCH methodology evaluation , *ANTI-infective agents , *EXPERIMENTAL design , *RESEARCH methodology , *STATISTICS , *DELPHI method , *INTER-observer reliability , *RELIABILITY (Personality trait) ,RESEARCH evaluation - Abstract
Antimicrobials prescribed without indications can lead to antimicrobial resistance (AMR). This study aimed to develop a validated support and audit antimicrobial prescription assessment tool (AmPAT) to assess the rationality of prescriptions by generalist medical doctors in outpatient settings at primary and secondary healthcare facilities. Multiphase content validity study. AmPAT was developed in four phases. Phase 1 involved item identification and development based on literature and expert suggestions. In phase 2, the face and content validity were assessed using the Delphi technique in two rounds (16 experts in round 1 and 19 in round 2). The content validity ratio (CVR) and content validity index (CVI) were calculated. A pilot study was conducted in Phase 3 in primary and secondary-level healthcare facilities (n = 92 prescriptions) in Chandigarh, India. Five experts assessed the rationality of 30 prescriptions for inter-rater reliability. The inter-rater agreement and internal consistency were calculated using Fleiss-Kappa statistics and Cronbach's alpha, respectively. Phase 4 included a large cross-sectional study (n = 945 prescriptions) for estimating the internal consistency of AmPAT. AmPAT was developed with 19 items under three sections (patient, clinical, and treatment details). The mean CVR was 0.91 (range 0.16–1.00), and mean CVI was 0.96 (range 0.58–1.00). The kappa value was 0.91 (range 0.59–1.00) for inter-rater agreement. The Cronbach's alpha was 0.75 (95%CI 0.66–0.82) and 0.76 (0.68–0.82) in phases 3 and 4, respectively. AmPAT, with good reliability, inter-rater agreement, and internal consistency, was developed to assess the rationality of antimicrobials prescribed in outpatient departments at primary and secondary-level healthcare settings. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF